These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 30374704)

  • 1. Impaired recovery in affective disorders and schizophrenia: sharing a common pathophysiology?
    Falkai P; Schmitt A; Koutsouleris N
    Eur Arch Psychiatry Clin Neurosci; 2018 Dec; 268(8):739-740. PubMed ID: 30374704
    [No Abstract]   [Full Text] [Related]  

  • 2. CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia.
    Hudson CJ; Young LT; Li PP; Warsh JJ
    Synapse; 1993 Mar; 13(3):278-93. PubMed ID: 8497811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Callosal dysfunction in schizophrenia and schizo-affective disorder.
    Craft S; Willerman L; Bigler ED
    J Abnorm Psychol; 1987 Aug; 96(3):205-13. PubMed ID: 3680758
    [No Abstract]   [Full Text] [Related]  

  • 4. [Auditory evoked potentials in patients with schizophrenia and affective disorders].
    Lebedeva IS; Abramova LI; Bondar' VV; Kaleda VG; Oleĭchik IV; Tsutsul'kovskaia MIa
    Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(1):56-60. PubMed ID: 11842625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal associations between mismatch negativity and disability in early schizophrenia- and affective-spectrum disorders.
    Kaur M; Lagopoulos J; Lee RS; Ward PB; Naismith SL; Hickie IB; Hermens DF
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():161-9. PubMed ID: 23851120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is the vigilance regulation model of affective disorders and ADHD also appropriate for other psychiatric disorders (schizophrenia, autism) and is it associated with glutamate?
    Niederhofer H
    Med Hypotheses; 2015 Mar; 84(3):281-2. PubMed ID: 25595841
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biological indices in schizo-affective disorders].
    Souetre E; Robert P; Darcourt G
    Encephale; 1987; 13(5):309-16. PubMed ID: 2827994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokines in affective disorders and schizophrenia: new clinical and genetic findings.
    Prolo P; Licinio J
    Mol Psychiatry; 1999 Mar; 4(2):109-11. PubMed ID: 10208441
    [No Abstract]   [Full Text] [Related]  

  • 9. MMN/P3a deficits in first episode psychosis: comparing schizophrenia-spectrum and affective-spectrum subgroups.
    Kaur M; Battisti RA; Ward PB; Ahmed A; Hickie IB; Hermens DF
    Schizophr Res; 2011 Aug; 130(1-3):203-9. PubMed ID: 21550211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune and neuroimmune alterations in mood disorders and schizophrenia.
    Drexhage RC; Weigelt K; van Beveren N; Cohen D; Versnel MA; Nolen WA; Drexhage HA
    Int Rev Neurobiol; 2011; 101():169-201. PubMed ID: 22050852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex, hormones and affective arousal circuitry dysfunction in schizophrenia.
    Goldstein JM
    Horm Behav; 2006 Nov; 50(4):612-22. PubMed ID: 16876167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endorphins and psychiatry.
    Blaszczynski AP; Winter SW
    Aust N Z J Psychiatry; 1984 Jun; 18(2):111-2. PubMed ID: 6593041
    [No Abstract]   [Full Text] [Related]  

  • 13. [The importance of interneurons in schizophrenic and affective disorders].
    Scherk H; Vogeley K; Falkai P
    Fortschr Neurol Psychiatr; 2003 Jul; 71 Suppl 1():S27-32. PubMed ID: 12947540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of physical exercise in schizophrenia and affective disorders.
    Malchow B; Reich-Erkelenz D; Oertel-Knöchel V; Keller K; Hasan A; Schmitt A; Scheewe TW; Cahn W; Kahn RS; Falkai P
    Eur Arch Psychiatry Clin Neurosci; 2013 Sep; 263(6):451-67. PubMed ID: 23873090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective compensation over early dysneurogenesis in schizophrenia and mood disorder.
    Maziade M; Paccalet T; Gilbert E
    Schizophr Res; 2018 Mar; 193():449-450. PubMed ID: 28666634
    [No Abstract]   [Full Text] [Related]  

  • 16. Limbic circuits and neuropsychiatric disorders. Functional anatomy and neuroimaging findings.
    Byrum CE; Thompson JE; Heinz ER; Krishnan KR; Tien RD
    Neuroimaging Clin N Am; 1997 Feb; 7(1):79-99. PubMed ID: 9100233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seasonal influences on admissions for mood disorders and schizophrenia in a teaching psychiatric hospital in Egypt.
    Amr M; Volpe FM
    J Affect Disord; 2012 Mar; 137(1-3):56-60. PubMed ID: 22244374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered pain perception and cerebrospinal endorphins in psychiatric illness.
    Davis GC; Buchsbaum MS; Naber D; Pickar D; Post R; van Kammen D; Bunney WE
    Ann N Y Acad Sci; 1982; 398():366-73. PubMed ID: 6961863
    [No Abstract]   [Full Text] [Related]  

  • 19. Electromyographic analysis of masseter and temporal muscles, bite force, masticatory efficiency in medicated individuals with schizophrenia and mood disorders compared with healthy controls.
    de Oliveira RH; Hallak JE; Siéssere S; de Sousa LG; Semprini M; de Sena MF; Osorio Fde L; Nunes EA; Pinto JP; Regalo SC
    J Oral Rehabil; 2014 Jun; 41(6):399-408. PubMed ID: 24661123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding schizoaffective disorder: from psychobiology to psychosocial functioning.
    Correll CU
    J Clin Psychiatry; 2010; 71 Suppl 2():8-13. PubMed ID: 21190647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.